Dr. White is currently an Infectious Diseases Clinical Pharmacist at the University of Oklahoma Medical Center. He works with the inpatient consult service, antimicrobial stewardship, and the outpatient parenteral antibiotic therapy program. His research interests include antimicrobial stewardship, resistant gram negative infections, and bloodstream infections.
Academic Section(s):
Infectious Diseases
Education:
2012 Doctor of Pharmacy
University of Georgia, Athens, GA
Residency:
2015 - 2016 PGY-2 Infectious Disease Pharmacy Residency
University of Mississippi Medical Center
Jackson, MS
2014 - 2015 PGY-1 Pharmacy Residency
Albany Medical Center
Albany, NY
Clinical/Research Interests:
Antimicrobial stewardship, rapid diagnostic technologies, and resistant gram-negative infections
Select Publications:
White BP, Lomaestro B, Pai MP. Optimizing the initial amikacin dosage in adults. Antimicrob Agents Chemother. 2015;59(11):7094-7096. doi:10.1128/AAC.01032-15
White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21(9):1208-1209. doi:10.1016/S1473-3099(21)00456-4
Fleming VH, White BP, Southwood R. Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. Am J Emerg Med. 2014;32(8):864-870. doi:10.1016/j.ajem.2014.04.033
White BP, Patel S, Tsui J, Chastain DB. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections. Infect Dis (Lond). 2019;51(3):161-167. doi:10.1080/23744235.2018.1527470
White BP, Stover KR, Barber KE, Galloway RC, Sullivan DC, King ST. Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp. Int J Antimicrob Agents. 2017;50(5):690-692. doi:10.1016/j.ijantimicag.2017.05.010
White BP, Barber KE, Chastain DB. Variation among infectious diseases pharmacists for the treatment of staphylococcus aureus bacteremia. J Pharm Pract. Published online August 16, 2021:8971900211038864. doi:10.1177/08971900211038864